Are you a Veteran of the United States Armed Forces?

Please complete a short survey about prostate cancer care for Veterans to help us learn what's working well and what needs improvement in the care Veterans receive.

Veterans prostate cancer care survey Complete the Survey

Avenda Health wins FDA breakthrough nod for AI-based prostate cancer treatment

Avenda Health logo

Avenda Health announced today that it received FDA breakthrough device designation for its AI-based male “lumpectomy” product.

Santa Monica. Calif.-based Avenda designed its lumpectomy product to treat prostate cancer in-office while preserving the quality of life through AI and minimally invasive technologies, according to a news release.

Read the full article here. 


Source: Mass Device

Share